FDA accepts BLA resubmission of pz-cel in recessive dystrophic epidermolysis bullosa and sets PDUFA target action date of April 29, 2025 Company makes significant progress toward potential commerciali ...
FDA accepts BLA resubmission of pz-cel in recessive dystrophic epidermolysis bullosa and sets PDUFA target action date of April 29, 2025Company ...
A few days ago, the ETH awarded the Salzburg University Clinic for Dermatology and Allergology of the PMU (Paracelsus Medical ...
Celebrating a Liverpool Legend’s Contributions to Football and CharityLiverpool’s Graeme Souness, an iconic figure in British ...
For years, he has been an active vice president of DEBRA UK, a charity devoted to supporting those affected by Epidermolysis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback